Abstract 832: An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

2018 ◽  
Author(s):  
Louise A. Koopman ◽  
Maarten L. Janmaat ◽  
Kirstine Jacobsen ◽  
Mikkel Green Terp ◽  
Elke Gresnigt-van den Heuvel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Specific Antibody ◽  
Small Cell ◽  
Egfr Inhibitor ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Anti Tumor Activity ◽  
Antibody Drug

scholarly journals Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models

mAbs ◽  
2014 ◽  
Vol 6 (2) ◽  
pp. 556-566 ◽  
Author(s):  
Kathleen R Whiteman ◽  
Holly A Johnson ◽  
Michele F Mayo ◽  
Charlene A Audette ◽  
Christina N Carrigan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Antitumor Activity ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Xenograft Models ◽  
Antibody Drug ◽  
Human Xenograft Models
Sign in / Sign up

Export Citation Format

Share Document